Sicart Associates LLC cut its holdings in shares of Nutrien Ltd. (NYSE:NTR - Free Report) by 6.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 84,282 shares of the company's stock after selling 5,692 shares during the quarter. Sicart Associates LLC's holdings in Nutrien were worth $3,770,000 as of its most recent SEC filing.
A number of other large investors have also added to or reduced their stakes in NTR. Silchester International Investors LLP increased its stake in shares of Nutrien by 164.4% during the third quarter. Silchester International Investors LLP now owns 10,683,242 shares of the company's stock worth $513,437,000 after purchasing an additional 6,642,075 shares during the period. Healthcare of Ontario Pension Plan Trust Fund bought a new position in Nutrien during the 3rd quarter worth $150,181,000. Bank of Montreal Can lifted its holdings in shares of Nutrien by 15.5% during the second quarter. Bank of Montreal Can now owns 13,354,385 shares of the company's stock worth $719,668,000 after buying an additional 1,794,333 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd boosted its position in shares of Nutrien by 78.8% in the third quarter. Clal Insurance Enterprises Holdings Ltd now owns 2,495,282 shares of the company's stock valued at $121,271,000 after acquiring an additional 1,100,000 shares during the period. Finally, Public Sector Pension Investment Board bought a new position in Nutrien during the second quarter worth about $38,176,000. Institutional investors own 63.10% of the company's stock.
Nutrien Trading Up 0.2 %
Shares of NTR stock traded up $0.09 during mid-day trading on Friday, reaching $51.59. 1,444,043 shares of the stock traded hands, compared to its average volume of 2,332,995. The company has a market cap of $25.33 billion, a price-to-earnings ratio of 34.62, a price-to-earnings-growth ratio of 1.11 and a beta of 0.81. The company has a quick ratio of 0.82, a current ratio of 1.27 and a debt-to-equity ratio of 0.38. The stock's fifty day simple moving average is $47.00 and its two-hundred day simple moving average is $47.90. Nutrien Ltd. has a 1-year low of $43.69 and a 1-year high of $60.87.
Nutrien (NYSE:NTR - Get Free Report) last posted its earnings results on Wednesday, November 6th. The company reported $0.39 EPS for the quarter, missing the consensus estimate of $0.43 by ($0.04). Nutrien had a return on equity of 6.99% and a net margin of 2.79%. The business had revenue of $5.35 billion for the quarter, compared to analyst estimates of $5.26 billion. During the same quarter in the prior year, the business earned $0.35 earnings per share. The firm's quarterly revenue was down 5.0% on a year-over-year basis. On average, research analysts anticipate that Nutrien Ltd. will post 3.5 EPS for the current fiscal year.
Nutrien Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, January 17th. Shareholders of record on Tuesday, December 31st will be given a $0.939 dividend. This represents a $3.76 dividend on an annualized basis and a dividend yield of 7.28%. The ex-dividend date is Tuesday, December 31st. This is a positive change from Nutrien's previous quarterly dividend of $0.54. Nutrien's payout ratio is 144.97%.
Wall Street Analysts Forecast Growth
A number of research analysts have issued reports on the stock. Raymond James upgraded shares of Nutrien from a "market perform" rating to an "outperform" rating and increased their target price for the stock from $58.00 to $60.00 in a research report on Tuesday, December 3rd. JPMorgan Chase & Co. raised Nutrien from an "underweight" rating to a "neutral" rating and increased their price target for the stock from $40.00 to $50.00 in a research report on Monday. Piper Sandler raised Nutrien from an "underweight" rating to an "overweight" rating and lifted their price objective for the company from $50.00 to $58.00 in a report on Monday. Wells Fargo & Company lowered Nutrien from an "overweight" rating to an "equal weight" rating and reduced their target price for the stock from $62.00 to $50.00 in a report on Tuesday, September 24th. Finally, UBS Group cut Nutrien from a "buy" rating to a "neutral" rating and decreased their price target for the stock from $66.00 to $51.00 in a research report on Thursday, October 10th. One research analyst has rated the stock with a sell rating, five have given a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $59.21.
Read Our Latest Stock Analysis on NTR
Nutrien Company Profile
(
Free Report)
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Read More
Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.